Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Eleda in connection with the acquisition of Signalbolaget i Sverige AB
Mandate

Vinge has advised Eleda in connection with the acquisition of Signalbolaget i Sverige AB

April 07, 2025 Employment and Benefits M&A Real Estate and Construction Banking and Finance FDI Data protection and processing of personal data

Signalbolaget is involved in the development and maintenance of the Swedish railway network, with a focus on services within signaling technology. Signalbolaget is based in Borlänge, Sweden, has a turnover of approximately SEK 80 million and 50 employees.

The transaction is subject to customary regulatory approval.

Vinge’s team consisted mainly of Christina Kokko, Ellen Flygt and Philip Moré (M&A), Daniel Wendelsson and David Olander (FDI), Emil Lindwall and Louisa Fagarasan (Employment), Calle Tengwall Pagels and Ida Appelgren (Banking and finance), Hanna Kövamees and Wilma Hellman (Real Estate), Nicklas Thorgerzon (GDPR) and Johanna Engström (Transaction Support Senior Coordinator).

 

 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026